PULM - Pulmatrix, Inc.
2.21
-0.020 -0.905%
Share volume: 7,620
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.23
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-08-2024 | 03-21-2025 | 05-15-2025 | 08-06-2025 | 10-16-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 30.391 M | 15.780 M | 11.510 M | 9.943 M | 8.051 M | 6.152 M | 4.982 M | 4.139 M | |
| Current Assets | 17.582 M | 15.636 M | 11.446 M | 9.920 M | 8.041 M | 6.142 M | 4.972 M | 4.129 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 16.300 M | 12.379 M | 10.782 M | 9.521 M | 7.708 M | 5.825 M | 4.794 M | 4.088 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.108 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 11.701 M | 144.000 K | 64.000 K | 23.000 K | 10.000 K | 10.000 K | 10.000 K | 10.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 30.391 M | 15.780 M | 11.510 M | 9.943 M | 8.051 M | 6.152 M | 4.982 M | 4.139 M | |
| Total liabilities | 11.373 M | 2.470 M | 590.000 K | 996.000 K | 904.000 K | 548.000 K | 249.000 K | 329.000 K | |
| Total current liabilities | 3.144 M | 2.470 M | 590.000 K | 929.000 K | 903.000 K | 548.000 K | 249.000 K | 329.000 K | |
| Accounts Payable | 721.000 K | 393.000 K | 373.000 K | 809.000 K | 657.000 K | 384.000 K | 69.000 K | 272.000 K | |
| Other liabilities | 8.229 M | 0.000 | 0.000 | 67.000 K | 1.000 K | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.229 M | 0.000 | 0.000 | 67.000 K | 1.000 K | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 19.018 M | 13.310 M | 10.920 M | 8.947 M | 7.147 M | 5.604 M | 4.733 M | 3.810 M | |
| Common stock | 305.790 M | 305.893 M | 306.090 M | 306.103 M | 306.111 M | 306.117 M | 306.123 M | 306.128 M | |
| Retained earnings | -286.772 M | -292.583 M | -295.170 M | -297.156 M | -298.964 M | -300.513 M | -301.390 M | -302.318 M |